LY 164846
| Code | Size | Price |
|---|
| TAR-T32990-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
LY 164846 is a novel oral cephalosporin that is effective against Staphylococcus, Streptococcus, Haemophilus influenzae, Catabella and Neisseria.
CAS:
92218-37-6
Formula:
C18H17N3O4S2
Molecular Weight:
403.47
Purity:
0.98
SMILES:
[H][C@@]12SCC(C)=C(N1C(=O)C2NC(=O)C(N)c1csc2ccccc12)C(O)=O
References
1. Sassine-Nawas G, Baker CN, Thornsberry C. Antimicrobial activity of LY164846, a new oral cephalosporin, and recommendations for disk diffusion tests. Diagn Microbiol Infect Dis. 1987 Jan;6(1):41-8. PubMed PMID: 3100126.
2. Jorgensen JH, Redding JS, Howell AW. Comparative activities of LY 164846 and other orally administered beta-lactam antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother. 1986 Jun;29(6):1090-1. PubMed PMID: 3488021; PubMed Central PMCID: PMC180505.
3. Lauderdale BL, Yu PK, Washington JA 2nd. In vitro activity of an orally administered cephalosporin, LY164846, against potentially pathogenic respiratory and dermal bacterial isolates. Antimicrob Agents Chemother. 1986 Apr;29(4):560-4. PubMed PMID: 3486628; PubMed Central PMCID: PMC180441.
4. Jones RN, Baker C, Barry AL, Fuchs PC. LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disks. Antimicrob Agents Chemother. 1986 Mar;29(3):530-4. PubMed PMID: 3755018; PubMed Central PMCID: PMC180430.